TrademarkOpen
Search / United States / 97926990

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

E

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics…
Show more

Class 5: Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases
Class 42: Medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS

Status timeline

  1. 12 May 2023
    Application filed
    New Application Entered
  2. 4 Sep 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 5 Sep 2023
    Office action issued
    Non-Final Action Written
  4. 4 Dec 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 5 Dec 2023
    Approved for publication
    Approved For Pub - Principal Register
  6. 9 Jan 2024
    Published for opposition
    Published For Opposition
  7. 5 Mar 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 10 Dec 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 7 Feb 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 5 Aug 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 40 events
2026-02-20Sou Teas Extension Received
2026-02-20Sou Extension 4 Filed
2026-02-20Sou Extension 4 Granted
2026-02-20Notice Of Approval Of Extension Request E-Mailed
2025-08-06Notice Of Approval Of Extension Request E-Mailed
2025-08-05Sou Teas Extension Received
2025-08-05Sou Extension 3 Filed
2025-08-05Sou Extension 3 Granted
2025-02-10Notice Of Approval Of Extension Request E-Mailed
2025-02-07Sou Teas Extension Received
2025-02-07Sou Extension 2 Filed
2025-02-07Sou Extension 2 Granted
2024-12-10Sou Extension 1 Granted
2024-12-10Notice Of Approval Of Extension Request E-Mailed
2024-12-09Case Assigned To Intent To Use Paralegal
2024-10-11Teas Change Of Owner Address Received
2024-10-11Applicant/Correspondence Changes (Non-Responsive) Entered
2024-10-11Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2024-10-11Attorney/Dom.rep.revoked And/Or Appointed
2024-10-11Teas Change Of Correspondence Received
2024-09-17Teas Petition To Revive Received
2024-09-17Petition To Revive-Granted
2024-09-17Notice Of Revival - E-Mailed
2024-09-17Sou Extension Received With Teas Petition
2024-09-05Sou Extension 1 Filed
2024-03-05Noa Mailed - Sou Required From Applicant
2024-01-09Published For Opposition
2024-01-09Official Gazette Publication Confirmation E-Mailed
2023-12-20Notification Of Notice Of Publication E-Mailed
2023-12-05Teas/Email Correspondence Entered
2023-12-05Approved For Pub - Principal Register
2023-12-04Teas Response To Office Action Received
2023-12-04Correspondence Received In Law Office
2023-09-05Non-Final Action Written
2023-09-05Non-Final Action E-Mailed
2023-09-05Notification Of Non-Final Action E-Mailed
2023-09-04Assigned To Examiner
2023-06-09Notice Of Design Search Code E-Mailed
2023-06-08New Application Office Supplied Data Entered
2023-05-12New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical and biological preparations based on genome editing and engineering for use in human therapeutics, namely, for the treatment of cancer and/or genetic diseases

Class 42 Technology & SaaS

Medical and scientific research information in the field of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical research and scientific research information in the fields of genome editing and engineering, gene modulation, gene repair, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 21 Feb 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.